SAN DIEGO, CA, November 1, 2021 (GLOBE NEWSWIRE) – via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first publicly traded cannabis company in the United States to launch the world’s first cannabis-derived products, brands and supply chain, today announced that the company’s subsidiary Kannawi® He promoted the General Manager of the Japan Division, Peter Dell, to the position of Global Sales Manager.
As the Director of Global Sales, Peter Dell will be responsible for overseeing the company’s global sales and business development teams, operations and strategy. He will continue to build his existing Kannaway® sales team with new employees and focus on improving overall productivity and effectiveness while strengthening his relationships with our entrepreneurs and customers.
“Peter has been instrumental in growing with our entrepreneurs in Japan and throughout Asia, and we believe he is able to successfully lead our sales operations globally,” said Blake Schroeder, CEO of Kannaway. “His dedication to our mission and vision is inspiring and I hope he can share his passion with more people than ever before in his new role.”
Dale is a senior multinational executive who has worked at Kannaway® since 2019, with over 30 years of experience in strategic leadership in large private and public companies such as Nerium International, Javita Japan, Waiora, LLC, Nature’s Sunshine Products, Rexall Showcase and Natural Health Trends, Inc.
“Being at Kannaway over the past two years has been very rewarding working closely with field leaders around the world, and I am ready to take on new challenges and responsibilities,” said Peter Dale, Chief Sales Officer, Kannaway. “I am excited to lead the company’s global sales strategy and provide continued service leadership in partnership with hard-working entrepreneurs, loyal customers and a dedicated sales team and deliver Kannaway’s growth initiatives through a pioneering customer-focused approach, ensuring revenue growth is sustainable throughout the year.”
Kannawi® is a network sales and marketing company specializing in the sale and marketing of plant based cannabis products. Currently, Kannaway® hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity for sales professionals who wish to become successful leaders in the sale and marketing of plant-based, hemp-based products.
About Medical Marijuana, Inc.
We are Firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company comprising three distinct business units in the non-psychoactive cannabis space: a global group of cannabis-based food brands led by Kannawi® And HempMeds®; A leader in sourcing high-quality, legal, non-psychoactive cannabis products derived from industrial hemp; and the sector of cannabis-based clinical research and development of plant-based medicines led by pharmaceutical investment firms and partners including AXIM® Biotechnologies, Inc. And Neuropathics. Medical Marijuana, Inc. was selected. As the best CBD product ever CNBC. Medical Marijuana, Inc. Also the first company to obtain historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a pioneer in developing international markets. The company’s main product Real scientific hemp oil It has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc. is headquartered in. In San Diego, California, additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. Watch the Medical Marijuana, Inc. video. , click here.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor law created by those sections. This material contains statements about expected future events and/or financial results of a forward-looking nature and subject to risks and uncertainties. These forward-looking statements by definition include risks, uncertainties and other factors, which could cause Medical Marijuana, Inc.’s actual results, performance or achievements to differ. materially from the data contained herein.
Disclosure by the Food and Drug Administration (FDA)
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Medical Marijuana, Inc. does not. Selling or distributing any products that violate the Controlled Substances Act in the United States.
Investor Relations Contact:
p. (858) 283-4016